- Home
- HKD vs RIGL Comparison
HKD vs RIGL Comparison
Compare HKD & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKD
- RIGL
- Stock Information
- Founded
- HKD 2003
- RIGL 1996
- Country
- HKD France
- RIGL United States
- Employees
- HKD N/A
- RIGL N/A
- Industry
- HKD Finance: Consumer Services
- RIGL Biotechnology: Pharmaceutical Preparations
- Sector
- HKD Finance
- RIGL Health Care
- Exchange
- HKD Nasdaq
- RIGL Nasdaq
- Market Cap
- HKD 595.6M
- RIGL 486.4M
- IPO Year
- HKD 2022
- RIGL 2000
- Fundamental
- Price
- HKD $2.72
- RIGL $21.81
- Analyst Decision
- HKD
- RIGL Buy
- Analyst Count
- HKD 0
- RIGL 5
- Target Price
- HKD N/A
- RIGL $34.80
- AVG Volume (30 Days)
- HKD 362.2K
- RIGL 347.9K
- Earning Date
- HKD 01-01-0001
- RIGL 03-04-2025
- Dividend Yield
- HKD N/A
- RIGL N/A
- EPS Growth
- HKD N/A
- RIGL N/A
- EPS
- HKD 0.33
- RIGL 0.22
- Revenue
- HKD $27,776,448.00
- RIGL $157,374,000.00
- Revenue This Year
- HKD N/A
- RIGL $51.34
- Revenue Next Year
- HKD N/A
- RIGL $15.75
- P/E Ratio
- HKD $8.29
- RIGL $98.50
- Revenue Growth
- HKD N/A
- RIGL 21.65
- 52 Week Low
- HKD $2.55
- RIGL $7.48
- 52 Week High
- HKD $5.80
- RIGL $29.82
- Technical
- Relative Strength Index (RSI)
- HKD 45.83
- RIGL 64.53
- Support Level
- HKD $2.55
- RIGL $17.28
- Resistance Level
- HKD $2.78
- RIGL $18.25
- Average True Range (ATR)
- HKD 0.19
- RIGL 1.37
- MACD
- HKD 0.00
- RIGL 0.65
- Stochastic Oscillator
- HKD 21.25
- RIGL 99.68
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. The company integrates various digital businesses using its AMTD SpiderNet ecosystem. Its reportable segments are; digital solutions services financial services; digital solutions services non-financial services, hotel operations, hospitality and VIP services, digital media, content and marketing services, and others. The company generates maximum revenue by providing financial digital solutions through its AMTD Risk Solutions, a digital insurance brokerage platform, and PolicyPal which is a digital insurance technology platform. Geographically, the company generates maximum revenue from Hong Kong and the rest from Canada and Singapore.
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.